Merit Medical Systems/$MMSI
MMSI shares drop as broader markets sell off after President Trump threatened a massive increase in tariffs on Chinese imports.
9 hours agoLightyear AI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Merit Medical Systems
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.
Ticker
$MMSI
Sector
Primary listing
Employees
7,400
Headquarters
Website
MMSI Metrics
BasicAdvanced
$4.9B
41.82
$1.97
0.58
-
Price and volume
Market cap
$4.9B
Beta
0.58
52-week high
$111.45
52-week low
$79.10
Average daily volume
668K
Financial strength
Current ratio
4.092
Quick ratio
2.509
Long term debt to equity
54.453
Total debt to equity
55.143
Interest coverage (TTM)
5.77%
Profitability
EBITDA (TTM)
281.59
Gross margin (TTM)
47.95%
Net profit margin (TTM)
8.31%
Operating margin (TTM)
11.60%
Effective tax rate (TTM)
21.19%
Revenue per employee (TTM)
$190,000
Management effectiveness
Return on assets (TTM)
4.19%
Return on equity (TTM)
8.60%
Valuation
Price to earnings (TTM)
41.817
Price to revenue (TTM)
3.379
Price to book
3.28
Price to tangible book (TTM)
11.59
Price to free cash flow (TTM)
25.525
Free cash flow yield (TTM)
3.92%
Free cash flow per share (TTM)
3.231
Growth
Revenue change (TTM)
10.11%
Earnings per share change (TTM)
-1.88%
3-year revenue growth (CAGR)
8.69%
10-year revenue growth (CAGR)
10.47%
3-year earnings per share growth (CAGR)
25.04%
10-year earnings per share growth (CAGR)
11.60%
What the Analysts think about MMSI
Analyst ratings (Buy, Hold, Sell) for Merit Medical Systems stock.
Bulls say / Bears say
Merit Medical reported Q2 2025 GAAP revenue of $382.5 million, a 13.2% year-over-year increase that exceeded the $374.2 million analyst consensus, underscoring strong demand across its product lines. (Nasdaq)
Non-GAAP operating margin reached a record 21.2% in Q2 2025, up 109 basis points year-over-year, reflecting improved operational efficiency and cost management. (Nasdaq)
Free cash flow rose 20% year-over-year to $70 million in Q2 2025, strengthening the company’s liquidity and balance sheet flexibility. (GuruFocus)
GAAP EPS declined 11.6% year-over-year to $0.54 in Q2 2025, indicating that reported profitability was pressured by integration and non-recurring expenses. (Nasdaq)
The endoscopy segment’s organic constant currency revenue grew just 1% in Q2 2025, highlighting underperformance in one of the company’s key growth areas. (Investing.com)
Cash and cash equivalents decreased to $341.8 million from $395.5 million sequentially while long-term debt rose to $731.8 million, elevating leverage and refinancing risk. (Zacks)
Data summarised monthly by Lightyear AI. Last updated on 2 Oct 2025.
MMSI Financial Performance
Revenues and expenses
MMSI Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Merit Medical Systems stock?
Merit Medical Systems (MMSI) has a market cap of $4.9B as of October 11, 2025.
What is the P/E ratio for Merit Medical Systems stock?
The price to earnings (P/E) ratio for Merit Medical Systems (MMSI) stock is 41.82 as of October 11, 2025.
Does Merit Medical Systems stock pay dividends?
No, Merit Medical Systems (MMSI) stock does not pay dividends to its shareholders as of October 11, 2025.
When is the next Merit Medical Systems dividend payment date?
Merit Medical Systems (MMSI) stock does not pay dividends to its shareholders.
What is the beta indicator for Merit Medical Systems?
Merit Medical Systems (MMSI) has a beta rating of 0.58. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.